Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 18/20 | 1.00 |
| ▸ | MMP3 | P08254 | 2/20 | 0.74 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.74 |
| ▸ | ADAM9 | Q13443 | 1/20 | 0.74 |
| ▸ | MMP1 | P03956 | 3/20 | 0.61 |
| ▸ | ADAM33 | Q9BZ11 | 2/20 | 0.56 |
| ▸ | MMP9 | P14780 | 2/20 | 0.56 |
| ▸ | MMP13 | P45452 | 2/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP14 | P50281 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL995718 | 1.00 | ADAM17 (1.00) | ADAM17MMP3ADAM10ADAM9MMP1 | |
| SCHEMBL995871 | 0.91 | ADAM17 (0.83) | ADAM17MMP3ADAM10ADAM9MMP1 | |
| SCHEMBL995872 | 0.91 | ADAM17 (0.83) | ADAM17MMP3ADAM10ADAM9MMP1 | |
| SCHEMBL14245241 | 0.88 | ADAM17 (1.00) | ADAM17MMP3ADAM10ADAM9MMP1 | |
| SCHEMBL996381 | 0.86 | ADAM17 (0.75) | ADAM17MMP3ADAM10ADAM9MMP1 | |
| SCHEMBL996380 | 0.86 | ADAM17 (0.75) | ADAM17MMP3ADAM10ADAM9MMP1 | |
| SCHEMBL1504826 | 0.85 | ADAM17 (1.00) | ADAM17MMP3ADAM10ADAM9MMP1 | |
| SCHEMBL1504804 | 0.85 | ADAM17 (1.00) | ADAM17MMP3ADAM10ADAM9MMP1 | |
| SCHEMBL1504678 | 0.85 | ADAM17 (1.00) | ADAM17MMP3ADAM10ADAM9MMP1 | |
| SCHEMBL996097 | 0.84 | ADAM17 (0.75) | ADAM17MMP3ADAM10ADAM9MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2801568-A1 | Benzene-sulphonamide compounds, method for synthesising and use in medicine and in cosmetics | Galderma Research & Development (FR) | 2014-11-12 | — | — | EP | claimed |
| EP-2448920-B1 | Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine | GALDERMA RES & DEV (FR) | 2014-08-13 | — | — | EP | claimed |
| EP-2448920-A1 | NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS | Galderma Research & Development (FR) | 2012-05-09 | — | — | EP | claimed |
| WO-2011001089-A1 | NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2011-01-06 | — | — | WO | claimed |
| EP-2801568-A1 | Benzene-sulphonamide compounds, method for synthesising and use in medicine and in cosmetics | Galderma Research & Development (FR) | 2014-11-12 | — | — | EP | disclosed |
| EP-2448920-B1 | Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine | GALDERMA RES & DEV (FR) | 2014-08-13 | — | — | EP | disclosed |
| EP-2448920-A1 | NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS | Galderma Research & Development (FR) | 2012-05-09 | — | — | EP | disclosed |
| WO-2011001089-A1 | NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2011-01-06 | — | — | WO | disclosed |